Table 2.
GSEA pathways | Sample size (n/m)1 | P value | GO categories | Count/Expected count | P value |
---|---|---|---|---|---|
Enriched in degenerative embryos2 | Biological process | ||||
Nuclear receptors | 23/40 | <0.001 | Cholesterol metabolic process | 10/1.4 | <0.001 |
Monoamine GPCRs | 20/33 | <0.001 | Steroid biosynthetic process | 8/1.5 | <0.001 |
Cell communication | 76/138 | <0.001 | Small GTPase mediated signal transduction | 18/8.3 | <0.001 |
GPCRs class A rhodopsin like | 78/185 | <0.001 | Cellular component | ||
Cytokine pathway | 18/22 | 0.003 | Endoplasmic reticulum membrane | 18/8.4 | 0.002 |
Enriched in normal embryos3 | Molecular function | ||||
Biosynthesis of steroids | 19/24 | <0.001 | Transferase activity, transferring alkyl or aryl groups | 6/1.4 | 0.002 |
Met pathway | 28/36 | 0.003 | |||
N-glycan biosynthesis | 34/42 | 0.005 | |||
Linoleic acid metabolism | 17/31 | 0.011 |
1 n = number of genes in the analyzed dataset; m = number of genes in the original gene set
2 Enrichment in degenerative embryo means significantly more genes in this gene set showed higher expression in degenerative embryos
3 Enrichment in blastocysts means significantly more genes in this gene set showed higher expression in blastocysts